Thakkar K, Kefalogianni R, Zhang J, Yung CF, et al. Clinical and economic benefits of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for prevention of RSV illness in infants: A cost-effectiveness analysis for Singapore. Vaccine 2026;75:128285.
PMID: 41619355